Haff, Madeleine G.
Mohanty, Arpan https://orcid.org/0000-0002-8408-8075
Funding for this research was provided by:
National Institute on Minority Health and Health Disparities (7R21MD01363)
Article History
Accepted: 21 April 2023
First Online: 9 May 2023
Compliance with Ethical Standards
:
: Dr. Haff declares that she has no conflict of interest. Author AM has received grants from Gilead and the Kinetix Group and has served on an advisory board for Gilead. She is also the principal investigator on phase 3 clinical trials for Intercept, Inventiva, and NovoNordisk.
: This article does not contain any studies with human or animal subjects performed by any of the authors.